 | • レポートコード：MRC2012B0125 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオマーカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオマーカーの種類別市場規模（敗血症バイオマーカー、抗生物質耐性バイオマーカー、外傷性脳損傷（TBI）検査バイオマーカー、脳卒中検査バイオマーカー、抗生物質管理バイオマーカー、その他）、用途別市場規模（診断、創薬、個別化医療、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher Scientific、Abbott、QIAGEN、Merck、Siemens Healthcare、Bio-Rad Laboratories、Danaher Corporation、Roche、Agilent Technologies、 ・地域別グローバル市場分析 2015年-2020年 ・バイオマーカーの北米市場（アメリカ、カナダ、メキシコ） ・バイオマーカーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオマーカーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオマーカーの南米市場（ブラジル、アルゼンチン） ・バイオマーカーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：敗血症バイオマーカー、抗生物質耐性バイオマーカー、外傷性脳損傷（TBI）検査バイオマーカー、脳卒中検査バイオマーカー、抗生物質管理バイオマーカー、その他 ・用途別分析：診断、創薬、個別化医療、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 14.0%% in the forecast period of 2020 to 2025 and will expected to reach USD 82360 million by 2025, from USD 48810 million in 2019.
Market segmentation
Biomarkers market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biomarkers market has been segmented into:
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other
By Application, Biomarkers has been segmented into:
Diagnostics
Drug Discovery
Personalized Medicine
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biomarkers market presented in the report. This section sheds light on the sales growth of different regional and country-level Biomarkers markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biomarkers market.
The report offers in-depth assessment of the growth and other aspects of the Biomarkers market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Biomarkers Market Share Analysis
Biomarkers competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biomarkers sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biomarkers sales, revenue and market share for each player covered in this report.
The major players covered in Biomarkers are:
Thermo Fisher Scientific
Abbott
QIAGEN
Merck
Siemens Healthcare
Bio-Rad Laboratories
Danaher Corporation
Roche
Agilent Technologies
Among other players domestic and global, Biomarkers market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Biomarkers Market Overview
1.1 Product Overview and Scope of Biomarkers
1.2 Classification of Biomarkers by Type
1.2.1 Global Biomarkers Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biomarkers Revenue Market Share by Type in 2019
1.2.3 Sepsis Biomarkers
1.2.4 Antibiotic Resistance Biomarkers
1.2.5 Traumatic Brain Injury (TBI) Testing Biomarkers
1.2.6 Stroke Testing Biomarkers
1.2.7 Antibiotic Stewardship Biomarkers
1.2.8 Other
1.3 Global Biomarkers Market by Application
1.3.1 Overview: Global Biomarkers Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Other
1.4 Global Biomarkers Market by Regions
1.4.1 Global Biomarkers Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biomarkers (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biomarkers Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biomarkers Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biomarkers Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biomarkers Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biomarkers Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott SWOT Analysis
2.2.4 Abbott Product and Services
2.2.5 Abbott Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.3 QIAGEN
2.3.1 QIAGEN Details
2.3.2 QIAGEN Major Business
2.3.3 QIAGEN SWOT Analysis
2.3.4 QIAGEN Product and Services
2.3.5 QIAGEN Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.5 Siemens Healthcare
2.5.1 Siemens Healthcare Details
2.5.2 Siemens Healthcare Major Business
2.5.3 Siemens Healthcare SWOT Analysis
2.5.4 Siemens Healthcare Product and Services
2.5.5 Siemens Healthcare Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Product and Services
2.6.4 Bio-Rad Laboratories Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.7 Danaher Corporation
2.7.1 Danaher Corporation Details
2.7.2 Danaher Corporation Major Business
2.7.3 Danaher Corporation Product and Services
2.7.4 Danaher Corporation Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Product and Services
2.8.4 Roche Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.9 Agilent Technologies
2.9.1 Agilent Technologies Details
2.9.2 Agilent Technologies Major Business
2.9.3 Agilent Technologies Product and Services
2.9.4 Agilent Technologies Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biomarkers Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biomarkers Players Market Share
3.2.2 Top 10 Biomarkers Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biomarkers Revenue and Market Share by Regions
4.2 North America Biomarkers Revenue and Growth Rate (2015-2020)
4.3 Europe Biomarkers Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biomarkers Revenue and Growth Rate (2015-2020)
4.5 South America Biomarkers Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biomarkers Revenue and Growth Rate (2015-2020)
5 North America Biomarkers Revenue by Countries
5.1 North America Biomarkers Revenue by Countries (2015-2020)
5.2 USA Biomarkers Revenue and Growth Rate (2015-2020)
5.3 Canada Biomarkers Revenue and Growth Rate (2015-2020)
5.4 Mexico Biomarkers Revenue and Growth Rate (2015-2020)
6 Europe Biomarkers Revenue by Countries
6.1 Europe Biomarkers Revenue by Countries (2015-2020)
6.2 Germany Biomarkers Revenue and Growth Rate (2015-2020)
6.3 UK Biomarkers Revenue and Growth Rate (2015-2020)
6.4 France Biomarkers Revenue and Growth Rate (2015-2020)
6.5 Russia Biomarkers Revenue and Growth Rate (2015-2020)
6.6 Italy Biomarkers Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biomarkers Revenue by Countries
7.1 Asia-Pacific Biomarkers Revenue by Countries (2015-2020)
7.2 China Biomarkers Revenue and Growth Rate (2015-2020)
7.3 Japan Biomarkers Revenue and Growth Rate (2015-2020)
7.4 Korea Biomarkers Revenue and Growth Rate (2015-2020)
7.5 India Biomarkers Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biomarkers Revenue and Growth Rate (2015-2020)
8 South America Biomarkers Revenue by Countries
8.1 South America Biomarkers Revenue by Countries (2015-2020)
8.2 Brazil Biomarkers Revenue and Growth Rate (2015-2020)
8.3 Argentina Biomarkers Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biomarkers by Countries
9.1 Middle East & Africa Biomarkers Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biomarkers Revenue and Growth Rate (2015-2020)
9.3 UAE Biomarkers Revenue and Growth Rate (2015-2020)
9.4 Egypt Biomarkers Revenue and Growth Rate (2015-2020)
9.5 South Africa Biomarkers Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biomarkers Revenue and Market Share by Type (2015-2020)
10.2 Global Biomarkers Market Forecast by Type (2019-2024)
10.3 Sepsis Biomarkers Revenue Growth Rate (2015-2025)
10.4 Antibiotic Resistance Biomarkers Revenue Growth Rate (2015-2025)
10.5 Traumatic Brain Injury (TBI) Testing Biomarkers Revenue Growth Rate (2015-2025)
10.6 Stroke Testing Biomarkers Revenue Growth Rate (2015-2025)
10.7 Antibiotic Stewardship Biomarkers Revenue Growth Rate (2015-2025)
10.8 Other Revenue Growth Rate (2015-2025)
11 Global Biomarkers Market Segment by Application
11.1 Global Biomarkers Revenue Market Share by Application (2015-2020)
11.2 Biomarkers Market Forecast by Application (2019-2024)
11.3 Diagnostics Revenue Growth (2015-2020)
11.4 Drug Discovery Revenue Growth (2015-2020)
11.5 Personalized Medicine Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Biomarkers Market Size Forecast (2021-2025)
12.1 Global Biomarkers Market Size Forecast (2021-2025)
12.2 Global Biomarkers Market Forecast by Regions (2021-2025)
12.3 North America Biomarkers Revenue Market Forecast (2021-2025)
12.4 Europe Biomarkers Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biomarkers Revenue Market Forecast (2021-2025)
12.6 South America Biomarkers Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biomarkers Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Biomarkers Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biomarkers Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biomarkers Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Biomarkers Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 7. Thermo Fisher Scientific Biomarkers Major Business
Table 8. Thermo Fisher Scientific Biomarkers Total Revenue (USD Million) (2017-2018)
Table 9. Thermo Fisher Scientific SWOT Analysis
Table 10. Thermo Fisher Scientific Biomarkers Product and Solutions
Table 11. Thermo Fisher Scientific Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Abbott Corporate Information, Location and Competitors
Table 13. Abbott Biomarkers Major Business
Table 14. Abbott Biomarkers Total Revenue (USD Million) (2018-2019)
Table 15. Abbott SWOT Analysis
Table 16. Abbott Biomarkers Product and Solutions
Table 17. Abbott Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. QIAGEN Corporate Information, Location and Competitors
Table 19. QIAGEN Biomarkers Major Business
Table 20. QIAGEN Biomarkers Total Revenue (USD Million) (2017-2018)
Table 21. QIAGEN SWOT Analysis
Table 22. QIAGEN Biomarkers Product and Solutions
Table 23. QIAGEN Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Merck Corporate Information, Location and Competitors
Table 25. Merck Biomarkers Major Business
Table 26. Merck Biomarkers Total Revenue (USD Million) (2017-2018)
Table 27. Merck SWOT Analysis
Table 28. Merck Biomarkers Product and Solutions
Table 29. Merck Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Siemens Healthcare Corporate Information, Location and Competitors
Table 31. Siemens Healthcare Biomarkers Major Business
Table 32. Siemens Healthcare Biomarkers Total Revenue (USD Million) (2017-2018)
Table 33. Siemens Healthcare SWOT Analysis
Table 34. Siemens Healthcare Biomarkers Product and Solutions
Table 35. Siemens Healthcare Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 37. Bio-Rad Laboratories Biomarkers Major Business
Table 38. Bio-Rad Laboratories Biomarkers Total Revenue (USD Million) (2017-2018)
Table 39. Bio-Rad Laboratories SWOT Analysis
Table 40. Bio-Rad Laboratories Biomarkers Product and Solutions
Table 41. Bio-Rad Laboratories Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Danaher Corporation Corporate Information, Location and Competitors
Table 43. Danaher Corporation Biomarkers Major Business
Table 44. Danaher Corporation Biomarkers Total Revenue (USD Million) (2017-2018)
Table 45. Danaher Corporation SWOT Analysis
Table 46. Danaher Corporation Biomarkers Product and Solutions
Table 47. Danaher Corporation Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Roche Corporate Information, Location and Competitors
Table 49. Roche Biomarkers Major Business
Table 50. Roche Biomarkers Total Revenue (USD Million) (2017-2018)
Table 51. Roche SWOT Analysis
Table 52. Roche Biomarkers Product and Solutions
Table 53. Roche Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Agilent Technologies Corporate Information, Location and Competitors
Table 55. Agilent Technologies Biomarkers Major Business
Table 56. Agilent Technologies Biomarkers Total Revenue (USD Million) (2017-2018)
Table 57. Agilent Technologies SWOT Analysis
Table 58. Agilent Technologies Biomarkers Product and Solutions
Table 59. Agilent Technologies Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Global Biomarkers Revenue (Million USD) by Players (2015-2020)
Table 61. Global Biomarkers Revenue Share by Players (2015-2020)
Table 62. Global Biomarkers Revenue (Million USD) by Regions (2015-2020)
Table 63. Global Biomarkers Revenue Market Share by Regions (2015-2020)
Table 64. North America Biomarkers Revenue by Countries (2015-2020)
Table 65. North America Biomarkers Revenue Market Share by Countries (2015-2020)
Table 66. Europe Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 67. Asia-Pacific Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 68. South America Biomarkers Revenue by Countries (2015-2020)
Table 69. South America Biomarkers Revenue Market Share by Countries (2015-2020)
Table 70. Middle East and Africa Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 71. Middle East and Africa Biomarkers Revenue Market Share by Countries (2015-2020)
Table 72. Global Biomarkers Revenue (Million USD) by Type (2015-2020)
Table 73. Global Biomarkers Revenue Share by Type (2015-2020)
Table 74. Global Biomarkers Revenue Forecast by Type (2021-2025)
Table 75. Global Biomarkers Revenue by Application (2015-2020)
Table 76. Global Biomarkers Revenue Share by Application (2015-2020)
Table 77. Global Biomarkers Revenue Forecast by Application (2021-2025)
Table 78. Global Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biomarkers Picture
Figure 2. Global Biomarkers Revenue Market Share by Type in 2019
Figure 3. Sepsis Biomarkers Picture
Figure 4. Antibiotic Resistance Biomarkers Picture
Figure 5. Traumatic Brain Injury (TBI) Testing Biomarkers Picture
Figure 6. Stroke Testing Biomarkers Picture
Figure 7. Antibiotic Stewardship Biomarkers Picture
Figure 8. Other Picture
Figure 9. Biomarkers Revenue Market Share by Application in 2019
Figure 10. Diagnostics Picture
Figure 11. Drug Discovery Picture
Figure 12. Personalized Medicine Picture
Figure 13. Other Picture
Figure 14. Global Biomarkers Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Biomarkers Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Biomarkers Revenue Market Share in 2019
Figure 23. Global Top 10 Players Biomarkers Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Biomarkers Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Biomarkers Revenue Market Share by Regions (2015-2020)
Figure 27. Global Biomarkers Revenue Market Share by Regions in 2018
Figure 28. North America Biomarkers Revenue and Growth Rate (2015-2020)
Figure 29. Europe Biomarkers Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Biomarkers Revenue and Growth Rate (2015-2020)
Figure 31. South America Biomarkers Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Biomarkers Revenue and Growth Rate (2015-2020)
Figure 33. North America Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 34. North America Biomarkers Revenue Market Share by Countries in 2019
Figure 35. USA Biomarkers Revenue and Growth Rate (2015-2020)
Figure 36. Canada Biomarkers Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Biomarkers Revenue and Growth Rate (2015-2020)
Figure 38. Europe Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Biomarkers Revenue Market Share by Countries in 2019
Figure 40. Germany Biomarkers Revenue and Growth Rate (2015-2020)
Figure 41. UK Biomarkers Revenue and Growth Rate (2015-2020)
Figure 42. France Biomarkers Revenue and Growth Rate (2015-2020)
Figure 43. Russia Biomarkers Revenue and Growth Rate (2015-2020)
Figure 44. Italy Biomarkers Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Biomarkers Revenue Market Share by Countries in 2019
Figure 47. China Biomarkers Revenue and Growth Rate (2015-2020)
Figure 48. Japan Biomarkers Revenue and Growth Rate (2015-2020)
Figure 49. Korea Biomarkers Revenue and Growth Rate (2015-2020)
Figure 50. India Biomarkers Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Biomarkers Revenue and Growth Rate (2015-2020)
Figure 52. South America Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 53. South America Biomarkers Revenue Market Share by Countries in 2019
Figure 54. Brazil Biomarkers Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Biomarkers Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Biomarkers Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Biomarkers Revenue and Growth Rate (2015-2020)
Figure 59. UAE Biomarkers Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Biomarkers Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Biomarkers Revenue and Growth Rate (2015-2020)
Figure 62. Global Biomarkers Revenue Share by Type (2015-2020)
Figure 63. Global Biomarkers Revenue Share by Type in 2019
Figure 64. Global Biomarkers Market Share Forecast by Type (2021-2025)
Figure 65. Global Sepsis Biomarkers Revenue Growth Rate (2015-2020)
Figure 66. Global Antibiotic Resistance Biomarkers Revenue Growth Rate (2015-2020)
Figure 67. Global Traumatic Brain Injury (TBI) Testing Biomarkers Revenue Growth Rate (2015-2020)
Figure 68. Global Stroke Testing Biomarkers Revenue Growth Rate (2015-2020)
Figure 69. Global Antibiotic Stewardship Biomarkers Revenue Growth Rate (2015-2020)
Figure 70. Global Other Revenue Growth Rate (2015-2020)
Figure 71. Global Biomarkers Revenue Share by Application (2015-2020)
Figure 72. Global Biomarkers Revenue Share by Application in 2019
Figure 73. Global Biomarkers Market Share Forecast by Application (2021-2025)
Figure 74. Global Diagnostics Revenue Growth Rate (2015-2020)
Figure 75. Global Drug Discovery Revenue Growth Rate (2015-2020)
Figure 76. Global Personalized Medicine Revenue Growth Rate (2015-2020)
Figure 77. Global Other Revenue Growth Rate (2015-2020)
Figure 78. Global Biomarkers Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Biomarkers Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Biomarkers Revenue Market Forecast (2021-2025)
Figure 82. Europe Biomarkers Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Biomarkers Revenue Market Forecast (2021-2025)
Figure 84. South America Biomarkers Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Biomarkers Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
ゲノミクスバイオマーカーの世界市場（～2026年） A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characterist…- 予測バイオマーカーの世界市場（～2026年） Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic. The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. Mar…
- 心臓バイオマーカーの世界市場（～2026年） Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These …
- EPOバイオマーカーの世界市場（～2026年） Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers are used to increase the growth of red blood cells in the body by stimulating the bone marrow. Major factors contributing to the growth of the global EPO biomarkers market include increasing sede…
- がん分子バイオマーカーの世界市場（～2026年） Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluid…